1. Home
  2. SRDX vs CGC Comparison

SRDX vs CGC Comparison

Compare SRDX & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • CGC
  • Stock Information
  • Founded
  • SRDX 1979
  • CGC N/A
  • Country
  • SRDX United States
  • CGC Canada
  • Employees
  • SRDX N/A
  • CGC 960
  • Industry
  • SRDX Medical/Dental Instruments
  • CGC Pharmaceuticals and Biotechnology
  • Sector
  • SRDX Health Care
  • CGC Health Care
  • Exchange
  • SRDX Nasdaq
  • CGC Nasdaq
  • Market Cap
  • SRDX 416.3M
  • CGC 427.4M
  • IPO Year
  • SRDX 1998
  • CGC N/A
  • Fundamental
  • Price
  • SRDX $28.87
  • CGC $1.45
  • Analyst Decision
  • SRDX Buy
  • CGC Hold
  • Analyst Count
  • SRDX 3
  • CGC 1
  • Target Price
  • SRDX $43.00
  • CGC N/A
  • AVG Volume (30 Days)
  • SRDX 138.2K
  • CGC 23.5M
  • Earning Date
  • SRDX 11-05-2025
  • CGC 11-07-2025
  • Dividend Yield
  • SRDX N/A
  • CGC N/A
  • EPS Growth
  • SRDX N/A
  • CGC N/A
  • EPS
  • SRDX N/A
  • CGC N/A
  • Revenue
  • SRDX $120,801,000.00
  • CGC $201,572,742.00
  • Revenue This Year
  • SRDX N/A
  • CGC $13.24
  • Revenue Next Year
  • SRDX $3.38
  • CGC $3.68
  • P/E Ratio
  • SRDX N/A
  • CGC N/A
  • Revenue Growth
  • SRDX N/A
  • CGC N/A
  • 52 Week Low
  • SRDX $26.00
  • CGC $0.77
  • 52 Week High
  • SRDX $40.39
  • CGC $5.80
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 25.36
  • CGC 52.79
  • Support Level
  • SRDX $29.54
  • CGC $1.33
  • Resistance Level
  • SRDX $30.19
  • CGC $1.46
  • Average True Range (ATR)
  • SRDX 0.74
  • CGC 0.10
  • MACD
  • SRDX -0.21
  • CGC -0.00
  • Stochastic Oscillator
  • SRDX 6.26
  • CGC 48.51

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About CGC Canopy Growth Corporation

Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

Share on Social Networks: